RDHL · RedHill Biopharma Ltd. · Documents
Market Cap
$3.75M
Shares
8.89M
Volume · Oct 23
108.09K
Avg daily vol (3M)
2.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2022-09-13 | — | |
| 6-K | — | 2022-08-26 | — | |
| 6-K | — | 2022-08-17 | — | |
| 6-K | — | 2022-07-12 | — | |
| 6-K | — | 2022-06-23 | — | |
| 6-K | — | 2022-06-22 | — | |
| 6-K | — | 2022-06-01 | — | |
| 6-K | — | 2022-05-25 | — | |
| 6-K | — | 2022-05-13 | — | |
| 6-K | — | 2022-05-12 | — | |
| 6-K | — | 2022-05-11 | — | |
| 6-K | — | 2022-05-09 | — | |
| 6-K | — | 2022-04-11 | — | |
| 6-K | — | 2022-04-05 | — | |
| 6-K | — | 2022-03-30 | — | |
| 6-K | — | 2022-03-17 | — | |
| 20-F | — | 2022-03-17 | 2021-12-31 | |
| 6-K | — | 2022-03-15 | — | |
| 6-K/A | — | 2022-03-08 | — | |
| 6-K | — | 2022-03-01 | — | |
| 6-K | — | 2022-02-17 | — | |
| 6-K | — | 2022-02-07 | — | |
| 6-K | — | 2022-01-13 | — | |
| 6-K | — | 2022-01-06 | — | |
| 6-K | — | 2021-12-15 | — | |
| 6-K | — | 2021-12-09 | — | |
| 6-K | — | 2021-12-06 | — | |
| 6-K | — | 2021-12-02 | — | |
| 6-K | — | 2021-12-01 | — | |
| 6-K | — | 2021-12-01 | — | |
| 6-K | — | 2021-11-30 | — | |
| 6-K | — | 2021-11-24 | — | |
| 6-K | — | 2021-11-22 | — | |
| 6-K | — | 2021-11-19 | — | |
| 6-K | — | 2021-11-18 | — | |
| 6-K | — | 2021-11-17 | — | |
| 6-K | — | 2021-11-15 | — | |
| 6-K | — | 2021-11-09 | — | |
| 6-K | — | 2021-11-08 | — | |
| 6-K | — | 2021-10-25 | — | |
| 6-K | — | 2021-10-20 | — | |
| 6-K | — | 2021-10-18 | — | |
| 6-K | — | 2021-10-12 | — | |
| 6-K | — | 2021-10-12 | — | |
| 6-K | — | 2021-10-06 | — | |
| 6-K | — | 2021-10-04 | — | |
| 6-K | — | 2021-09-23 | — | |
| 6-K | — | 2021-09-14 | — | |
| 6-K | — | 2021-09-13 | — | |
| 6-K | — | 2021-09-07 | — |
Showing 201–250 of 382 filings